Literature DB >> 1589395

Analysis of hydroxyurea in capsules and aqueous solution and stability study with capillary gas chromatography and thermionic (N-P) specific detection.

A el-Yazigi1, S al-Rawithi.   

Abstract

A method for the analysis of hydroxyurea (HU) in solutions, powder, or capsules by use of capillary gas chromatography with N-P thermionic specific detection is described. Upon injection of an HU solution in a methanol and acetone mixture, the drug formed pyridine which was well separated from the internal standard (thiotepa) on a 30-m fused-silica, SE-30 capillary column with temperature programming. The peak height ratio versus concentration standard curves were linear with correlation coefficient ranging between 0.9942 and 0.9993. The coefficients of variation at 5, 25, and 50 micrograms/L were 7.2, 5.7, and 5.5%, respectively. Hydroxyurea was extracted from powder or capsule formulations with a mixture of methanol and acetone (50:50, v:v), and the percentage found of the label claim for 10 capsules ranged between 96.7 and 104.9 (mean = 100.1; CV = 2.7%). Further, this assay was used to examine the stability of hydroxyurea in aqueous solutions at 4, 23, and 45 degrees C, and the apparent first-order rate constants observed at these temperatures were 0.06407, 0.08113, and 0.1293 day-1, respectively; the activation energy was 3011 cal.K-1.mol-1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1589395     DOI: 10.1023/a:1018996130753

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  6 in total

1.  Excretion of hydroxyurea into milk.

Authors:  R K Sylvester; M Lobell; M E Teresi; D Brundage; R Dubowy
Journal:  Cancer       Date:  1987-11-01       Impact factor: 6.860

2.  High-performance liquid chromatographic analysis of hydroxyurea in pharmaceutical formulations and in the bulk.

Authors:  J Pluscec; Y C Yuan
Journal:  J Chromatogr       Date:  1986-07-18

3.  Determination of hydroxyurea in mammalian tissues and blood.

Authors:  E Fabricius; F Rajewsky
Journal:  Rev Eur Etud Clin Biol       Date:  1971 Aug-Sep

4.  Hydroxyurea reversal of inhibition and use as a cell-synchronizing agent.

Authors:  R L Adams; J G Lindsay
Journal:  J Biol Chem       Date:  1967-03-25       Impact factor: 5.157

5.  Hydroxyurea-induced inhibition of deoxyribonucleotide synthesis: studies in intact cells.

Authors:  C W Young; G Schochetman; D A Karnofsky
Journal:  Cancer Res       Date:  1967-03       Impact factor: 12.701

6.  Studies of hydroxyurea administered by continuous infusion: toxicity, pharmacokinetics, and cell synchronization.

Authors:  R J Belt; C D Haas; J Kennedy; S Taylor
Journal:  Cancer       Date:  1980-08-01       Impact factor: 6.860

  6 in total
  2 in total

Review 1.  Pharmacokinetics and pharmacodynamics of hydroxyurea.

Authors:  P R Gwilt; W G Tracewell
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

2.  Cyanide, peroxide and nitric oxide formation in solutions of hydroxyurea causes cellular toxicity and may contribute to its therapeutic potency.

Authors:  Kawai J Kuong; Andrei Kuzminov
Journal:  J Mol Biol       Date:  2009-05-23       Impact factor: 5.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.